Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
AgomAb Therapeutics NV
SIC 2836 · Biological Products, (No Diagnostic Substances)
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
AgomAb Therapeutics NV
SIC 2836 · Biological Products, (No Diagnostic Substances)
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
AgomAb Therapeutics NV
SIC 2836 · Biological Products, (No Diagnostic Substances)
Notes
Support
about
terms
$
AGMB
AgomAb Therapeutics NV
CIK:
0002020932
|
SEC Filings
ARTICLES AND BYLAWS
EX-3.1
tm267896d1_ex3-1.htm
2026-03-05T00:00:00Z
EX-3.1
tm2415594d20_ex3-1.htm
2026-02-09T00:00:00Z
EX-3.1
tm2415594d10_ex3-1.htm
2026-01-16T00:00:00Z
EX-3.2
tm2415594d10_ex3-2.htm
2026-01-16T00:00:00Z
EX-3.1
filename2.htm
2025-10-28T00:00:00Z
EX-3.1
filename2.htm
2024-06-20T00:00:00Z